Correction: Timing is Everything: Neoadjuvant Versus Adjuvant Immunotherapy in Patients with Resectable Metastatic Melanoma (Annals of Surgical Oncology, (2023), 30, 12, (6953-6957), 10.1245/s10434-023-14133-8)

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Correction: Timing is Everything: Neoadjuvant Versus Adjuvant Immunotherapy in Patients with Resectable Metastatic Melanoma (Annals of Surgical Oncology, (2023), 30, 12, (6953-6957), 10.1245/s10434-023-14133-8)'. Together they form a unique fingerprint.

Medicine & Life Sciences